taurine has been researched along with Necrosis in 31 studies
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Descending necrotizing mediastinitis is a rare complication of upper respiratory infections." | 5.39 | Descending mediastinitis managed by sternotomy, taurolidine and delayed closure. ( Iyer, AP; Kugathasan, G; Kuteyi, O; Larbalestier, R; Malik, P; Prabha, R, 2013) |
| "Taurine was found to significantly correlate with apoptotic cell density (TUNEL) in both non-necrotic (R=0." | 5.35 | Taurine: a potential marker of apoptosis in gliomas. ( Bell, BA; Griffiths, JR; Howe, FA; Opstad, KS, 2009) |
| "Ischemia-reperfusion injury is of major clinical relevance during liver transplantation." | 5.33 | Taurine protects against ischemia-reperfusion injury in rabbit livers. ( Jiang, H; Li, J; Meng, F; Qiao, H; Sun, X; Tong, L, 2006) |
| "Our results indicate that taurine has protective effects on hyperhomocysteinemia-induced toxicity by decreasing oxidative and nitrosative stresses, apoptosis, and necrosis in the liver." | 3.75 | Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. ( Doğru-Abbasoğlu, S; Giriş, M; Olgaç, V; Unlüçerçi, Y; Uysal, M; Yalçinkaya, S, 2009) |
| "This study demonstrates that donor preconditioning with taurine protects kidney grafts from injury (apoptosis, necrosis), improves graft function, and increases the regenerative potential most likely via mechanisms including antioxidation." | 3.74 | Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. ( Büchler, MW; Dei-Anane, G; Gross, ML; Guan, X; Kern, M; Liang, R; Ludwig, J; Nickkholgh, A; Schemmer, P; Schmidt, J; Zeier, M, 2008) |
| " Hepatotoxic compounds such as CCl4, galactosamine and thioacetamide that cause hepatic necrosis and compounds such as hydrazine and ethionine that cause fatty liver all result in elevated urinary taurine levels in rats." | 3.69 | Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro. ( Timbrell, JA; Waterfield, CJ, 1996) |
| "This study was designed to test the hypothesis that the antioxidant taurine may modulate human endothelial cell (EC) death (apoptosis versus necrosis)." | 3.69 | The beneficial effect of taurine on the prevention of human endothelial cell death. ( Bouchier-Hayes, D; Condron, C; Redmond, HP; Wang, JH; Watson, RW, 1996) |
| "To evaluate the potential role of the semi-amino acid taurine in the prevention of hepatocyte (HC) apoptosis and necrosis mediated by nitric oxide (NO) and reactive oxygen intermediates." | 3.69 | Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. ( Bouchier-Hayes, D; Redmond, HP; Wang, JH, 1996) |
| "Descending necrotizing mediastinitis is a rare complication of upper respiratory infections." | 1.39 | Descending mediastinitis managed by sternotomy, taurolidine and delayed closure. ( Iyer, AP; Kugathasan, G; Kuteyi, O; Larbalestier, R; Malik, P; Prabha, R, 2013) |
| "Taurine was found to significantly correlate with apoptotic cell density (TUNEL) in both non-necrotic (R=0." | 1.35 | Taurine: a potential marker of apoptosis in gliomas. ( Bell, BA; Griffiths, JR; Howe, FA; Opstad, KS, 2009) |
| "Ischemia/reperfusion injury is mediated by various mechanisms." | 1.35 | Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury. ( Backhaus, J; Büchler, MW; Flechtenmacher, C; Gebhard, MM; Kincius, M; Liang, R; Schemmer, P; Schindler, G; Zorn, M, 2009) |
| "Ischemia-reperfusion injury is of major clinical relevance during liver transplantation." | 1.33 | Taurine protects against ischemia-reperfusion injury in rabbit livers. ( Jiang, H; Li, J; Meng, F; Qiao, H; Sun, X; Tong, L, 2006) |
| "Taurine (200 mg/kg) was given 12 h before, at the time of, and 1 or 2 h after acetaminophen injection." | 1.31 | Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. ( Bouchier-Hayes, D; Kay, E; Redmond, HP; Wang, JH; Waters, E; Wu, QD, 2001) |
| "Taurine was given orally to rats to determine its influence on survival of subdermal plexus skin flaps." | 1.29 | Failure of oral taurine supplementation to influence skin-flap survival in rats. ( Basher, AW; Hanna, PE; Novotny, MJ, 1995) |
| "The taurine pretreatment had no effect on the metabolism of 14CCl4 in hepatic microsomes and antioxidant content in the liver, but significantly enhanced the CCl4-induced increase in hepatic Ca++ content." | 1.27 | Pretreatment with taurine facilitates hepatic lipid peroxide formation associated with carbon tetrachloride intoxication. ( Kuriyama, K; Nakashima, T; Takino, T, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (19.35) | 18.7374 |
| 1990's | 7 (22.58) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 4 (12.90) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, X | 1 |
| Xu, H | 1 |
| Barker, RG | 1 |
| Lamb, GD | 1 |
| Murphy, RM | 1 |
| Hemminki, O | 1 |
| Immonen, R | 1 |
| Närväinen, J | 1 |
| Kipar, A | 1 |
| Paasonen, J | 1 |
| Jokivarsi, KT | 1 |
| Yli-Ollila, H | 1 |
| Soininen, P | 1 |
| Partanen, K | 1 |
| Joensuu, T | 1 |
| Parvianen, S | 1 |
| Pesonen, SK | 1 |
| Koski, A | 1 |
| Vähä-Koskela, M | 1 |
| Cerullo, V | 1 |
| Pesonen, S | 1 |
| Gröhn, OH | 1 |
| Hemminki, A | 1 |
| Iyer, AP | 1 |
| Kugathasan, G | 1 |
| Prabha, R | 1 |
| Malik, P | 1 |
| Kuteyi, O | 1 |
| Larbalestier, R | 1 |
| Stacchiotti, A | 1 |
| Rovetta, F | 1 |
| Ferroni, M | 1 |
| Corsetti, G | 1 |
| Lavazza, A | 1 |
| Sberveglieri, G | 1 |
| Aleo, MF | 1 |
| Yalçinkaya, S | 1 |
| Unlüçerçi, Y | 1 |
| Giriş, M | 1 |
| Olgaç, V | 1 |
| Doğru-Abbasoğlu, S | 1 |
| Uysal, M | 1 |
| Opstad, KS | 1 |
| Bell, BA | 1 |
| Griffiths, JR | 1 |
| Howe, FA | 1 |
| Schindler, G | 1 |
| Kincius, M | 2 |
| Liang, R | 3 |
| Backhaus, J | 1 |
| Zorn, M | 1 |
| Flechtenmacher, C | 2 |
| Gebhard, MM | 2 |
| Büchler, MW | 3 |
| Schemmer, P | 3 |
| Sinha, M | 1 |
| Manna, P | 1 |
| Sil, PC | 1 |
| O'Donnell, DH | 1 |
| Moloney, MA | 1 |
| Bouchier-Hayes, DJ | 2 |
| Lee, MJ | 1 |
| Takahashi, K | 2 |
| Ohyabu, Y | 1 |
| Solodushko, V | 1 |
| Takatani, T | 1 |
| Itoh, T | 2 |
| Schaffer, SW | 1 |
| Azuma, J | 1 |
| GOYER, RA | 2 |
| YIN, MW | 2 |
| BOWDEN, DH | 1 |
| Condron, CM | 1 |
| Toomey, DM | 1 |
| Casey, RG | 1 |
| Creagh, T | 1 |
| Bunzendahl, H | 1 |
| Gutt, CN | 1 |
| Mehrabi, A | 1 |
| Kraus, TW | 1 |
| Tong, L | 1 |
| Li, J | 1 |
| Qiao, H | 1 |
| Jiang, H | 1 |
| Meng, F | 1 |
| Sun, X | 1 |
| Xu, YJ | 1 |
| Saini, HK | 1 |
| Zhang, M | 1 |
| Elimban, V | 1 |
| Dhalla, NS | 1 |
| Belsey, MJ | 1 |
| Davies, AR | 1 |
| Witchel, HJ | 1 |
| Kozlowski, RZ | 1 |
| Guan, X | 1 |
| Dei-Anane, G | 1 |
| Gross, ML | 1 |
| Nickkholgh, A | 1 |
| Kern, M | 1 |
| Ludwig, J | 1 |
| Zeier, M | 1 |
| Schmidt, J | 1 |
| Azari, J | 1 |
| Brumbaugh, P | 1 |
| Barbeau, A | 1 |
| Huxtable, R | 1 |
| Nakashima, T | 1 |
| Takino, T | 1 |
| Kuriyama, K | 1 |
| Basher, AW | 1 |
| Novotny, MJ | 1 |
| Hanna, PE | 1 |
| Draper, RP | 1 |
| Waterfield, CJ | 2 |
| York, MJ | 1 |
| Timbrell, JA | 2 |
| Nakata, N | 1 |
| Kato, H | 1 |
| Kogure, K | 1 |
| Wang, JH | 4 |
| Redmond, HP | 4 |
| Watson, RW | 1 |
| Condron, C | 1 |
| Bouchier-Hayes, D | 4 |
| Wu, QD | 2 |
| Fennessy, F | 1 |
| Wang, L | 1 |
| Sun, J | 1 |
| Li, L | 1 |
| Harbour, C | 1 |
| Mears, D | 1 |
| Koutalistras, N | 1 |
| Sheil, AG | 1 |
| Waters, E | 1 |
| Kay, E | 1 |
| Vankemmel, M | 1 |
| Scherpereel, P | 1 |
| Pfirrmann, RW | 1 |
| Kitamura, Y | 1 |
| Kamisaki, Y | 1 |
31 other studies available for taurine and Necrosis
| Article | Year |
|---|---|
Elevated MMP2 abundance and activity in mdx mice are alleviated by prenatal taurine supplementation.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Female; Male; Matrix Metalloproteinase 2; Matr | 2020 |
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders.
Topics: Adenoviridae; Animals; Biomarkers, Tumor; Carcinoma; Cells, Cultured; Choline; Cricetinae; Fatty Aci | 2014 |
Descending mediastinitis managed by sternotomy, taurolidine and delayed closure.
Topics: Aged; Anti-Infective Agents, Local; Combined Modality Therapy; Drainage; Empyema, Pleural; Humans; M | 2013 |
Taurine rescues cisplatin-induced muscle atrophy in vitro: a morphological study.
Topics: Adenine; Animals; Apoptosis; Autophagy; Cell Line; Cisplatin; Mice; Muscle Fibers, Skeletal; Muscula | 2014 |
Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine.
Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; bcl-2-Associate | 2009 |
Taurine: a potential marker of apoptosis in gliomas.
Topics: Apoptosis; Biomarkers, Tumor; Brain Neoplasms; Cell Count; Glioma; Humans; In Situ Nick-End Labeling | 2009 |
Fundamental efforts toward the development of a therapeutic cocktail with a manifold ameliorative effect on hepatic ischemia/reperfusion injury.
Topics: Alanine; Animals; Arginine; Chemotaxis, Leukocyte; Clinical Enzyme Tests; Drug Therapy, Combination; | 2009 |
Induction of necrosis in cadmium-induced hepatic oxidative stress and its prevention by the prophylactic properties of taurine.
Topics: Analysis of Variance; Animals; Antioxidants; Cadmium; Cadmium Chloride; Cytochrome P-450 Enzyme Syst | 2009 |
Contrast-induced nephrotoxicity: possible synergistic effect of stress hyperglycemia.
Topics: Acetylcysteine; Analysis of Variance; Animals; Apoptosis; Contrast Media; Dogs; Hyperglycemia; Kidne | 2010 |
Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes.
Topics: Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Myocardial Ischem | 2003 |
TAURINE EXCRETION FOLLOWING DRUG-INDUCED MUSCLE NECROSIS AND X-IRRADIATION.
Topics: Diaphragm; Heart Diseases; Isoproterenol; Muscular Diseases; Necrosis; Radiation Injuries; Radiation | 1964 |
Taurine protects against PMN dysfunction and death in urine.
Topics: Adult; Apoptosis; CD11b Antigen; Cell Death; Down-Regulation; Escherichia coli; Female; Flow Cytomet | 2004 |
Taurine improves graft survival after experimental liver transplantation.
Topics: Animals; Cell Communication; Endothelial Cells; Enzymes; Female; Graft Survival; Kupffer Cells; Leuk | 2005 |
Taurine protects against ischemia-reperfusion injury in rabbit livers.
Topics: Animals; Disease Models, Animal; Injections, Intravenous; Kinetics; Lipid Peroxidation; Liver; Liver | 2006 |
MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Calcium; Enzyme Activation; Enzyme-Li | 2006 |
Inhibition of ERK and JNK decreases both osmosensitive taurine release and cell proliferation in glioma cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anthracenes; Apoptosis; Astrocytoma; Cell | 2007 |
Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation.
Topics: Animals; Apoptosis; Biopsy; Caspase 3; Dose-Response Relationship, Drug; Female; Graft Rejection; HS | 2008 |
Taurine and creatine excretion after x-irradiation and plasmocid-induced muscle necrosis in the rat.
Topics: Animals; Antimalarials; Creatine; Mononuclear Phagocyte System; Muscles; Necrosis; Quinolines; Radia | 1967 |
Taurine decreases lesion severity in the hearts of cardiomyopathic hamsters.
Topics: Adult; Aged; Animals; Calcium; Cardiomyopathies; Cricetinae; Humans; Iron; Magnesium; Male; Mesocric | 1980 |
Pretreatment with taurine facilitates hepatic lipid peroxide formation associated with carbon tetrachloride intoxication.
Topics: Animals; Calcium; Carbon Tetrachloride; Iron; Lipid Peroxides; Liver; Male; Microsomes, Liver; NADP; | 1983 |
Failure of oral taurine supplementation to influence skin-flap survival in rats.
Topics: Administration, Oral; Animals; Male; Necrosis; Rats; Rats, Sprague-Dawley; Surgical Flaps; Taurine; | 1995 |
Studies on the muscle toxicant 2,3,5,6-tetramethyl p-phenylenediamine: effects on various biomarkers including urinary creatine and taurine.
Topics: Animals; Biomarkers; Body Weight; Creatine; Dose-Response Relationship, Drug; Male; Muscles; Muscula | 1994 |
Effects of repeated cerebral ischemia on extracellular amino acid concentrations measured with intracerebral microdialysis in the gerbil hippocampus.
Topics: Amino Acids; Animals; Brain Ischemia; Disease Models, Animal; Extracellular Space; gamma-Aminobutyri | 1993 |
Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cells, Cultured; Clenbute | 1996 |
The beneficial effect of taurine on the prevention of human endothelial cell death.
Topics: Apoptosis; Arsenites; Calcimycin; Calcium; Cell Death; Cells, Cultured; DNA; Dose-Response Relations | 1996 |
Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury.
Topics: Animals; Cells, Cultured; Lipopolysaccharides; Liver; Necrosis; Nitrates; Nitric Oxide; Rats; Rats, | 1996 |
Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis.
Topics: Antioxidants; Apoptosis; Arsenites; Calcium; Cells, Cultured; Diabetic Angiopathies; Diuretics, Osmo | 1999 |
Factors affecting hepatocyte viability and CYPIA1 activity during encapsulation.
Topics: Alginates; Animals; Apoptosis; Biocompatible Materials; Calcium; Calcium Chloride; Calcium Compounds | 2000 |
Role of taurine in preventing acetaminophen-induced hepatic injury in the rat.
Topics: Acetaminophen; Alanine Transaminase; Alkaline Phosphatase; Analgesics, Non-Narcotic; Animals; Apopto | 2001 |
[Focalized irrigation-lavage and sequential use of a new antiseptic by local and general route. Preliminary report apropos of 2 cases of suppurative pancreatic necrosis].
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Drug Tolerance; Female; Humans; Inje | 1978 |
Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
Topics: Acetaminophen; Alkynes; Animals; Cystathionine; Glutathione; Glycine; Liver; Male; Necrosis; Pargyli | 1989 |